ProMIS Financial Statements From 2010 to 2026

ProMIS Neurosciences Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 22.8 M 21.7 M 7.4 M Slightly volatile Total Current Liabilities 2 M 2.6 M 2.1 M Slightly volatile Accounts Payable 1.4 M 2 M 1.3 M Slightly volatile Cash 16 M 15.3 M 5.7 M Slightly volatile Cash And Short Term Investments 16.1 M 15.3 M 6 M Slightly volatile Net Receivables 97.2 K 70.2 K 73.2 K Slightly volatile Common Stock Shares Outstanding 1.3 M 1.2 M 330.6 K Slightly volatile Short Term Investments 28.3 K 29.7 K 308.2 K Slightly volatile Liabilities And Stockholders Equity 22.8 M 21.7 M 7.4 M Slightly volatile Non Current Liabilities Total 223.8 K 235.6 K 1.4 M Pretty Stable Other Current Assets 6.7 M 6.3 M 1.4 M Slightly volatile Other Stockholder Equity 129.9 M 123.7 M 47.1 M Slightly volatile Total Liabilities 3 M 2.8 M 3.2 M Slightly volatile Total Current Assets 22.8 M 21.7 M 7.4 M Slightly volatile Intangible Assets 43.6 K 25.4 K 53.4 K Slightly volatile Common Stock 38.3 M 65 M 40.4 M Slightly volatile Current Deferred Revenue 133 K 149.6 K 163.3 K Slightly volatile Short and Long Term Debt Total 6 M 5.7 M 3.1 M Slightly volatile Short Term Debt 83.3 K 80.9 K 99 K Slightly volatile Property Plant Equipment 274 289 13.2 K Very volatile Property Plant And Equipment Gross 80.4 K 72.3 K 82.1 K Pretty Stable Other Liabilities 1.6 M 1.7 M 6.8 M Slightly volatile Long Term Debt 3.1 M 3.5 M 3.8 M Slightly volatile
ProMIS Neurosciences Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Other Operating Expenses 20.3 M 19.4 M 8.9 M Slightly volatile Research Development 12.8 M 12.2 M 5.3 M Slightly volatile Total Operating Expenses 20.3 M 19.4 M 7.8 M Slightly volatile Selling General Administrative 7.5 M 7.1 M 3.1 M Slightly volatile Selling And Marketing Expenses 1.2 M 1.2 M 406.9 K Slightly volatile Cost Of Revenue 10.1 M 12 M 7.1 M Slightly volatile Interest Income 5.7 K 5.4 K 1.9 K Slightly volatile
ProMIS Neurosciences Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 15.2 M 14.5 M 4.5 M Slightly volatile Other Cashflows From Financing Activities 30.6 K 32.2 K 1 M Very volatile Total Cash From Financing Activities 33.7 M 32.1 M 10.6 M Slightly volatile End Period Cash Flow 16 M 15.3 M 5.2 M Slightly volatile Stock Based Compensation 423.3 K 743.2 K 502.6 K Pretty Stable Issuance Of Capital Stock 33.6 M 32 M 11.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 5.1 K 5.3 K 17.4 K Very volatile Days Sales Outstanding 1.1 K 1.4 K 1.2 K Pretty Stable Invested Capital 592.2 K 623.4 K 14 M Slightly volatile Average Payables 4.5 M 4.3 M 2.2 M Slightly volatile Stock Based Compensation To Revenue 226 238 291 Pretty Stable Capex To Depreciation 0.19 0.2 3.8223 Slightly volatile EV To Sales 3.3 K 3.5 K 16.1 K Very volatile Payables Turnover 1.45 1.53 7.4015 Slightly volatile Sales General And Administrative To Revenue 348 366 754 Pretty Stable Research And Ddevelopement To Revenue 520 547 1.6 K Very volatile Capex To Revenue 0.64 0.68 33.0898 Slightly volatile Cash Per Share 14.04 14.78 36.6753 Slightly volatile Days Payables Outstanding 259 247 105 Slightly volatile Net Current Asset Value 519 583 637 Slightly volatile Tangible Asset Value 567 638 697 Slightly volatile Intangibles To Total Assets 0.0033 0.0035 0.0693 Slightly volatile Current Ratio 6.41 9.8 4.771 Very volatile Receivables Turnover 0.33 0.35 14.2703 Slightly volatile Graham Number 24.78 27.87 30.422 Slightly volatile Debt To Equity 0.7 0.62 0.5744 Slightly volatile Capex Per Share 0.0072 0.0076 0.6598 Slightly volatile Average Receivables 81.5 K 90.1 K 67.5 K Slightly volatile Revenue Per Share 0.0384 0.0404 0.6126 Slightly volatile Interest Debt Per Share 0.0809 0.0852 6.375 Very volatile Debt To Assets 0.12 0.2 0.166 Slightly volatile Operating Cycle 1.1 K 1.4 K 1.2 K Pretty Stable Days Of Payables Outstanding 259 247 105 Slightly volatile Long Term Debt To Capitalization 0.33 0.37 0.4015 Slightly volatile Total Debt To Capitalization 0.32 0.37 0.3282 Slightly volatile Debt Equity Ratio 0.7 0.62 0.5744 Slightly volatile Quick Ratio 6.42 9.8 4.79 Very volatile Net Income Per E B T 0.83 0.94 1.0261 Slightly volatile Cash Ratio 5.66 5.39 2.803 Slightly volatile Days Of Sales Outstanding 1.1 K 1.4 K 1.2 K Pretty Stable Free Cash Flow Operating Cash Flow Ratio 1.13 1.15 1.0321 Slightly volatile Fixed Asset Turnover 1.51 1.58 3.3387 Slightly volatile Debt Ratio 0.12 0.2 0.166 Slightly volatile Price Sales Ratio 5.1 K 5.3 K 17.4 K Very volatile Asset Turnover 4.0E-4 4.0E-4 0.0549 Slightly volatile
ProMIS Neurosciences Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 24.9 M 22.1 M 27.9 M Pretty Stable Working Capital 519 583 637 Slightly volatile Enterprise Value 9.6 M 10.2 M 22.4 M Pretty Stable

ProMIS Fundamental Market Drivers

ProMIS Upcoming Events

About ProMIS Neurosciences Financial Statements

Pair Trading with ProMIS Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:

How To Invest In ProMIS Details

Is ProMIS Stock a good investment? Details

What is ProMIS Neurosciences' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details